<DOC>
	<DOCNO>NCT02483052</DOCNO>
	<brief_summary>RejuvenAir System treatment perform preoperative bronchoscopy 2 90 day prior prescheduled lung resection Subjects require lobectomy removal peripheral tumor . Treatment limit area bronchi within lobe remove , distal anticipate margin resection . Treatment least 1 cm bronchial resection margin away tumor bed . Treated airways inspect via bronchoscopy time thoracotomy , examine histologically follow surgical resection . Subject participation 1 90 day enrollment anticipate take 3 month . Subject RejuvenAir procedure go resection reason follow maximum 90 day safety undergo bronchoscopic evaluation treat airway 90 day ( +/- 4 Days ) ) post treatment .</brief_summary>
	<brief_title>RejuvenAir Lobectomy Safety Histology</brief_title>
	<detailed_description>The study prospective , open label , single arm , single center study . The objective study safety RejuvenAir System population subject schedule undergo plan lobectomy . A secondary objective determine histological effect RejuvenAir System treatment airway . The Primary Endpoint Safety measure occurrence serious adverse event relate meter dose radial spray cryotherapy treatment perform prior schedule lobectomy surgery . The patient population intend participate study subject schedule undergo lobectomy peripheral lung lesion suspicious know cancer . Secondarily , enable understanding histological characteristic heal outcomes post-treatment airway , resect . CSA Medical conduct bench animal study support use RejuvenAir System sufficiently safe effective warrant advance product primary safety study patient present consideration lobectomy . Such patient provide safe population clinical evaluation system subject receive lobectomy procedure 2 14 day follow delivery meter liquid nitrogen treatment . At time meter liquid nitrogen treatment operate room set thoracic surgeon attendance . It anticipate subject agree participate study meter liquid nitrogen treatment time evaluation lung lesion . This evaluation include bronchoscopy ultrasound evaluation lymph node prior plan surgical resection lung abnormality .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Males females 21 75 year age . Subject able read , understand , sign write Informed Consent participate study . Subject schedule within 90 day date study treatment lobectomy unrelated study ( upper low lobe ) . Preferred range 214 day study treatment . Subject preprocedure post bronchodilator FEV1 great equal 40 % predict . Subject able undergo bronchoscopy opinion investigator per hospital guideline . Subject able adhere undergo schedule bronchoscope procedure prior clinically schedule lobectomy surgical procedure . â€¢ Subject pregnant , nursing , plan get pregnant study duration . Subject schedule pneumonectomy previous contralateral pneumonectomy . Subject prior radiation therapy involve lung . Subject receive chemotherapy within past 6 month , anticipate treat chemotherapy initial study treatment lobectomy procedure . Subject acute pulmonary infection pneumonia within 6 week prior study bronchoscopy . Subject COPD exacerbation within 6 week prior study bronchoscopy . Subject bronchiectasis area treat . Subject bullous emphysema . Characterized large bulla &gt; 3 centimeter confirm CT. Subject Lung transplant . Subject lung reduction surgery , include implant emphysema stent ( ) implant , coil device treatment .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>lobectomy</keyword>
	<keyword>spray cryotherapy</keyword>
	<keyword>lung cancer</keyword>
</DOC>